MICHELLE BALLARD: Open Payments
NPI 1114599289 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,391 in 125 payments from 21 companies in 2025. Trend: 2023 $1,692 · 2024 $3,088 · 2025 $2,391
Food & beverage: $2,231Education: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $455 |
| Amgen Inc. | 24 | $346 |
| Janssen Biotech, Inc. | 14 | $332 |
| ANI Pharmaceuticals, Inc. | 6 | $218 |
| Radius Health, Inc. | 10 | $168 |
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| UCB, Inc. | 7 | $151 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
Products named: TREMFYA, RINVOQ, PURIFIED CORTROPHIN GEL, Tymlos, COSENTYX, SKYRIZI, Bimzelx, ENBREL.
Industry payments across UT — which companies pay providers there.
